We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.30 | 3.20 | 3.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.26 | 2.98M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/3/2022 07:12 | Placing 100% now. | jasonpugh | |
23/3/2022 07:09 | Well that's that then | reidy66 | |
22/3/2022 20:06 | Maybe we wait till end of month before anyone starts judging?"The sub-license completion is subject to a successful fund-raise, with completion anticipated by end-Q1 2022." | wulber | |
22/3/2022 18:32 | Suzy taking the Michael now. Appears she does lack the ability to get a deal over the line. | francoismyname | |
20/3/2022 10:36 | 2p a day rise coming until news as last week, then it’s all down to how good it is imho. | 412069 | |
18/3/2022 16:09 | Not yet my friend! | wulber | |
18/3/2022 15:36 | Drinking ?Charts ?Lol | nico115 | |
18/3/2022 15:04 | Thought the volume would have been higher today due to fomo | reidy66 | |
18/3/2022 14:13 | It should have been performance related at least | sooty snipes | |
18/3/2022 13:59 | Porky, Nico - hopefully Cenkos might earn their crust by getting II's lined up to support any placing required to fund a lab or other value enhancing acquisition? Just a query, keen to know your thoughts..GLA | lagansider | |
18/3/2022 13:41 | NB - I also consider we got bloody mugged by CENKOS. Gifted 5% of the business for £40 to £50k's worth of work, if that. Still no II support | porky9 | |
18/3/2022 13:37 | @412069 I am not being a f'cking me me person at all, this board is to discuss the stock is it not? As you know so much about this company and i don't please expand:- 1. If you "once owned" 4% and everything is so great why are you not holding 4% now? or were you in at 6p and top sliced and now in for free? 2. How much are TheoremRx actually raising? Do you know? 3. What is the ownership of TheoremRx? Does Kevin own any of it? Does anyone else? 4. Can you be sure they can fund future milestone payments? or is that subject to further raises that could be a risk? 5. Where's the prospectus, company details? in fact ANY details? 6. We now have a change of business plan to create a lab and services SPV within the business, How much are VAL then intending to fund the lab? 7. Are we going to be hit with a placing for the lab? when the forward details are further expanded on the 6th April. Reality is that much of this is in the dark as well you know it. It didn't have to be that way did it? Full disclosure and clarity from the start would have cleared much of this up. We await how events unfold Agree no point in being known as a tw@t. But if the stock discussion group here is only for those that don't challenge anything how can informed investment decisions be made? I am not a yes person, never have been. BUT i do like to be in receipt of the bulk of the facts to make investment decisions. Good luck to you anyway | porky9 | |
18/3/2022 13:18 | Just broken up through the 200 dma 8@D | wulber | |
18/3/2022 13:08 | Exactly my thoughts Sooty"Give us 5pct of the equity for nothing,we will get you institutions on board and we willStill charge you extortionate fees "Shame on them We got mugged | nico115 | |
18/3/2022 11:48 | It's one of the reasons I'm not too sure of Suzy. Wet round the ears or what. We got absolutely mugged giving them 5% with nothing in return. Not one single institutional investor which is what I assume they were hired and paid for. | sooty snipes | |
18/3/2022 11:37 | Cenkos.... a director by rns as well today he knows he's going to make a few quid from VAL this coming year i bet. | 412069 | |
18/3/2022 10:20 | I see Cenkos is up on good results today. No wonder if they can do deals like the one with us. Get 5% of the company and do beggar-all for it! | sooty snipes | |
18/3/2022 09:50 | For those who do not know I think the TheoremRx fund raise is for its Portfolio and not just specifically for Val. Therein lies the perceived delay methinks. | carlisle44 | |
18/3/2022 07:23 | We are staying positive share price wise everyday right up to the news then it doubles minimum from there if it’s signed. I also think there maybe more than just 201 news on the day | 412069 | |
18/3/2022 06:44 | Porky, you have to look at the total package with THX which for new applications would mean VAL should be looking at receiving a 9 figure some in time, which l have. GL | wulber | |
18/3/2022 05:34 | @Wulber I have done significant research here as best i can, as i do all the positions i take. I totally agree that in the Bio world these things take time BUT that is not the issue here as i see it. The CEO gave a specific time line of year end which wasn't met and then by RNS confirmed by quarter end 31/3. This is a FIRM commitment. In addition it was intimated /confirmed this was very much a long-stop date so shareholders are now rightfully concerned that its getting closer to the wire. Now hopefully come open the RNS will be there, happy days. If not there are still 9 days to the quarter end but they will need to update. A number of investors are VERY excited that this deal will land and the share price will rise and lets hope so, it has done so the last few days which is encouraging. Personally i was VERY skeptical about this deal, i really don't like it, however the decision was made and i have to respect that. Further, this week the CEO was incredibly bullish that this is just a formality now so much so that i believe the Update will land confirming its completion. However, it doesn't stop there for me. Because the cash upfront from this deal is so pitiful, even with the deal over the line they remain bootstrap with barely enough capital to cover the years costs and that is only providing all the milestones are met, it's going to be tight. Now Unless one of the other drugs comes over the line they have no other means of income. So from the analysis i have done, you can't convince me otherwise that a placing won't be required here:- a) If the deal doesn't land they run out of cash in about May based on CENKOS report so a placing to shore up capital is absolutely guaranteed in that event IMO. b) If the deal lands, as they remain bootstrap and as they have now changed the business plan and want to buy a lab, which will add value so possibly a value add here, a placing will be required for that anyhow imo. The presentation 6/4 i believe COULD be to launch that placing. So in my considered opinion, the best outcome is the deal completes, share price rises and placing is at a higher valuation level and II support. Worse case the deal doesn't complete and they are forced into an emergency placing at discount. We will know soon enough but for now im not adding to my position. That's how i see it. I will consider a placing for a new lab IF that proves to be the case. | porky9 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions